doi:10.3969/j.issn.1673-8640.2015.11.016

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 11

[1]	叶应妩,王毓三,申子瑜. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社,2006:360.
[2]	中华医学会糖尿病学分会.中国2型糖尿病防治指南[M]. 北京: 北京大学医学出版社,2007:1-65
[3]	YANG W,LU J,WENG J,et al.Prevalence of diabetes among men and women in China[J]. N Engl J Med,2010,362(12):1090-1101.
[4]	柴秀莲,王立岩,刘吉武,等. 北京西南地区城市人群血压、血脂、血糖状况调查分析[J]. 北京医学,2010,32(2): 123-126 .
[5]	刘玉枝,王凤玲,郑晓丽,等. 19 169名体检者空腹血糖检测结果分析[J]. 检验医学与临床,2012,9(18):2372.
[6]	王红卫,朱翠凤,刘颜,等. 深圳市体检人群脂肪肝及其相关危险因素流行病学特点分析[J]. 现代预防医学,2013,40(6):1003-1006.
[7]	秦枫. 重庆市体检人群血脂和血糖异常情况的分析[J]. 中国当代医药,2013,20(35):91-92.
[8]	钱德富,姜志华,任慧,等. 14 044例体检职工的血脂血糖水平分析[J]. 临床心血管病杂志,2013,29(8):613-617.
[9]	职心乐,王建华. 天津2型糖尿病患病情况调查及相关危险因素研究[J]. 中国糖尿病杂志,2009,17(4):275-277.
[10]	谢颖,王云芳,沈春燕,等. 5 326例机关工作人员血糖、血脂和尿酸结果分析[J]. 检验医学,2014,29(1): 95-96.
[11]	周凤春. 6 082例接受体检人员糖代谢异常情况调查分析[J]. 中华保健医学杂志,2010,12(2):138-139.

年龄 (岁)	男性		女性			P值
年龄 (岁)	例数	FBG	例数		FBG	P值
20~	1 118	4.84±0.82	1 016	4.70±0.47		0.005
30~	1 425	4.95±0.99	1 071	4.81±0.54		0.003
40~	1 521	5.17±1.33	1 106	4.99±0.93		0.000
50~	1 123	5.48±1.60	934	5.28±1.31		0.000
≥60	1 708	5.65±1.65	775	5.51±1.37		0.006
合计	6 895	5.24±1.38	4 902	5.03±1.01		0.000

年龄 (岁)	男性		女性			P值
年龄 (岁)	例数	FBG	例数		FBG	P值
20~	1 118	4.84±0.82	1 016	4.70±0.47		0.005
30~	1 425	4.95±0.99	1 071	4.81±0.54		0.003
40~	1 521	5.17±1.33	1 106	4.99±0.93		0.000
50~	1 123	5.48±1.60	934	5.28±1.31		0.000
≥60	1 708	5.65±1.65	775	5.51±1.37		0.006
合计	6 895	5.24±1.38	4 902	5.03±1.01		0.000

年龄(岁)	男性	女性
20~	4.84±0.82	4.70±0.47
30~	4.95±0.99	4.81±0.54
40~	5.17±1.33^*#	4.99±0.93^*#
50~	5.48±1.60^*#△	5.28±1.31^*#△
≥60	5.65±1.65^*#△▲	5.51±1.37^*#△▲

年龄(岁)	男性	女性
20~	4.84±0.82	4.70±0.47
30~	4.95±0.99	4.81±0.54
40~	5.17±1.33^*#	4.99±0.93^*#
50~	5.48±1.60^*#△	5.28±1.31^*#△
≥60	5.65±1.65^*#△▲	5.51±1.37^*#△▲

年龄(岁)	男性		女性		χ²值	P值
年龄(岁)	例数	FBG升高率	例数	FBG升高率	χ²值	P值
20~	1 118	35(3.13)	1 016	18(1.77)	4.06	0.044
30~	1 425	58(4.07)	1 071	28(2.61)	3.90	0.048
40~	1 521	152(9.99)^*#	1 106	55(4.97)^*#	22.24	0.000
50~	1 123	182(16.21)^*#△	934	95(10.17) ^*#△	15.94	0.000
≥60	1 708	331(19.38)^*#△▲	775	135(17.42) ^*#△▲	1.34	0.246
合计	6 895	758(10.99)	4 902	331(6.75%)	61.50	0.000

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 11

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.